Literature DB >> 15565945

Skin sensitization to common allergens in Turkish wheezy children less than 3 years of age.

Ozkaya Emin1, Güler Nermin, Oneş Ulker, Gülbin Gökçay.   

Abstract

Infants and small children with asthma are not commonly skin tested, as allergy is not considered to be a major cause of infantile asthma. The aim of this study was to determine the frequency of skin test positivity to various allergens in wheezy children less than 3 years of age. We evaluated 161 patients with infantile asthma (median age 20 months) and 100 healthy controls (median age 18 months). Infantile asthma was defined as three or more episodes of wheezing in a child less than 3 years of age, whose symptoms improved on treatment with beta-agonist and anti-inflammatory agents. All children were skin tested to house dust mites (HDM), pollens, molds, and cow milk extracts using prick technique. One hundred and eighteen (73.3%) children In the patient group tested positive to HDM, 84 (52.1%) to pollens, 37 (22.9%) to molds, and 16 (10%) to cow milk. Sensitization rates to HDM were significantly higher in the patient group than In the healthy controls. Sensitization rates to pollens were not statistically different between the two groups. There was no association between family history of atopy and frequency of sensitization to allergens in the wheezy and control groups. We concluded that skin sensitization to allergens was common In wheezy infants. The prevalence of sensitization to indoor allergens was higher than to outdoor or food allergens.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15565945

Source DB:  PubMed          Journal:  Asian Pac J Allergy Immunol        ISSN: 0125-877X            Impact factor:   2.310


  2 in total

1.  House dust mite control measures in the treatment of asthma.

Authors:  Gillian Vallance; Charles McSharry; Stuart Wood; Neil C Thomson
Journal:  Ther Clin Risk Manag       Date:  2006-12       Impact factor: 2.423

2.  Risk factors for recurrent wheezing in infants: a case-control study.

Authors:  Roberta Barros de Sousa; Décio Medeiros; Emanuel Sarinho; José Ângelo Rizzo; Almerinda Rêgo Silva; Ana Carolina Dela Bianca
Journal:  Rev Saude Publica       Date:  2016-05-03       Impact factor: 2.106

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.